Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Interest Expenses (2018 - 2023)

Rapid Therapeutic Science Laboratories' Interest Expenses history spans 6 years, with the latest figure at $60831.0 for Q2 2023.

  • For Q2 2023, Interest Expenses fell 92.05% year-over-year to $60831.0; the TTM value through Jun 2023 reached $588604.0, down 78.87%, while the annual FY2022 figure was $1.9 million, 43.19% up from the prior year.
  • Interest Expenses for Q2 2023 was $60831.0 at Rapid Therapeutic Science Laboratories, down from $111026.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $765590.0 in Q2 2022 and bottomed at $3309.0 in Q2 2021.
  • The 5-year median for Interest Expenses is $62361.5 (2020), against an average of $226334.6.
  • The largest annual shift saw Interest Expenses soared 23036.6% in 2022 before it tumbled 92.05% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $34823.0 in 2019, then crashed by 51.78% to $16792.0 in 2020, then soared by 3763.23% to $648714.0 in 2021, then tumbled by 89.12% to $70576.0 in 2022, then dropped by 13.81% to $60831.0 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Interest Expenses are $60831.0 (Q2 2023), $111026.0 (Q1 2023), and $70576.0 (Q4 2022).